New pathogenic mechanisms in Burkitt lymphoma

Nature Genetics

Volumn 44, Issue 12, 2012, Pages 1288-1289

  Campo, Elias ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; INHIBITOR OF DIFFERENTIATION 3; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; TRANSCRIPTION FACTOR 7 LIKE 1;

ARTICLE; BURKITT LYMPHOMA; CANCER DIAGNOSIS; CANCER PATIENT; CELL CYCLE; CELL PROLIFERATION; DOWN REGULATION; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GERMINAL CENTER; HUMAN; IMMUNE DEFICIENCY; LARGE CELL LYMPHOMA; MOLECULAR PATHOLOGY; NONHUMAN; ONCOGENE MYC; PRIORITY JOURNAL; SOMATIC MUTATION; STRUCTURAL GENOMICS; UPREGULATION;

BURKITT LYMPHOMA; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEINS; MUTATION; NEOPLASM PROTEINS;

EID: 84870551856     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2476     Document Type: Article

References (12)

1. Wright, D. Br. J. Haematol. 156, 780-782 (2012).
2. Dalla-Favera, R. et al. Proc. Natl. Acad. Sci. USA 79, 7824-7827 (1982).
3. Magrath, I. Br. J. Haematol. 156, 744-756 (2012).
4. Janz, S. et al. Genes Chrom. Cancer 36, 211-223 (2003).
5. Richter, J. et al. Nat. Genet. 44, 1316-1320 (2012).
6. Love, C. et al. Nat. Genet. 44, 1321-1325 (2012).
7. Schmitz, R. et al. Nature 490, 116-120 (2012).
8. Seitz, V. et al. PLoS One 6, e26837 (2011).
9. Sander, S. Cancer Cell 22, 167-179 (2012).
10. Victora, G.D. et al. Blood 120, 2240-2248 (2012).
11. Salaverria, I. & Siebert, R. J. Clin. Oncol. 29, 1835-1843 (2011).
12. Molyneux, E.M. et al. Lancet 379, 1234-1244 (2012).